Klinicki centar Nis (Site 3322)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Kidney cancer

Running trials

• Active, not recruiting

  A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)

  NCT04736706· Phase 3· Merck Sharp & Dohme LLC· Source